A carregar...
Co-occurring Genomic Alterations and Association With Progression-Free Survival in BRAF(V600)-Mutated Nonmelanoma Tumors
BRAF(V600) mutations occur in multiple nonmelanoma tumors, but no US Food and Drug Administration–approved BRAF-targeted therapies exist for these cancers. BRAF inhibitor vemurafenib was recently found to demonstrate activity across various BRAF-mutated nonmelanoma cancer types. However, most tumors...
Na minha lista:
| Publicado no: | J Natl Cancer Inst |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6059192/ https://ncbi.nlm.nih.gov/pubmed/29117359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djx094 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|